Olszewski, J. et al. 2024. Mirikizumab – a new option in the treatment of inflammatory bowel diseases. Prospects in Pharmaceutical Sciences. 22, 3 (Sep. 2024), 178–185. DOI:https://doi.org/10.56782/pps.262.